Myoclonus & Startle

Contributed by Marcelo Merello, MD
Director, Neuroscience Department
Head Movement Disorders Section
Institute for Neurological Research Raul Carrea (FLENI)
Buenos Aires, Argentina


2019 updates contributed by:
Sterre van der Veen, MD, PhD Candidate,
Movement Disorders Groningen, under Marina de Koning-Tijssen, MD, PhD
Head of Movement Disorders, Department of Neurology, Movement disorders
Groningen, Netherlands

Myoclonus is characterized by sudden, brief, involuntary jerks of a muscle or group of muscles. It can be either a positive jerk caused by a muscular contraction, or a negative jerk caused by an interruption of muscle activity. The classification of myoclonus can be made anatomical, clinical or etiological; however, the anatomical origin of jerks is most commonly used in clinical practice. With help of electrophysiological examination using electromyography in combination with electro-encephalography, the jerks can be subdivided in cortical – which is the most common –subcortical (or non-cortical) including brainstem, spinal, and peripheral myoclonus. The clinical presentation of myoclonus is of added value in the differentiation of these subtypes. Cortical myoclonus present mainly in distal limbs and the face are stimulus-sensitive, opposed to subcortical myoclonus showing mostly proximal and axial jerks.

A wide variety of both acquired and genetic causes are associated with myoclonus, making the diagnostic process of finding the etiology challenging. Both the anatomical substrate and the additional accompanying clinical features provide important information regarding the underlying disease and help guide towards a more specific differential diagnosis.

Acquired causes

In cortical and subcortical myoclonus, an acquired cause is common and characterized by an acute or subacute onset and/or fast progression of disease. Medication or toxic agents induced myoclonus should be considered first, especially if the jerky movements started more or less acutely at the start of treatment, because cessation or detoxification will ameliorate the symptoms. Subsequently, routine laboratory tests can detect etiologies such as homeostatic imbalance, organ failure and infections. Immune-mediated disorders (e.g. anti-NMDAR encephalitis, stiff person syndrome (SPS), opsoclonus-myoclonus syndromes (OMS)) become more likely one systemic signs of infection are present. Some of these disorders are treatable and, therefore, early recognition is critical. A brain MRI is a helpful next step in identifying the underlying disease, both acquired and genetic causes.

In spinal and peripheral myoclonus, signs of muscle denervation or structural lesions must be assessed with help of electrophysiological testing or imaging. Propriospinal myoclonus, closely resembling spinal myoclonus and characterized by generalized jerks of the trunk and abdominal muscles with a variable duration from 100 – 1000ms, is usually a functional movement disorder.

Genetic causes

Only cortical and subcortical myoclonus are associated with genetic disorders and in most cases next generation sequencing (NGS) is indicated after ruling out an acquired cause. However, keep in mind the mitochondrial disorders (e.g. MERRF) and neurodegenerative disorders (e.g. Alzheimer’s disease) for mitochondrial defects are not identified with NGS and in only a small percentage of neurodegenerative disorders the underlying defect is known.

Compared to an acquired cause, a genetically determined myoclonus syndrome is suspected in cases with an early onset and a slower progression of disease. In the majority of cases, one of two clinical syndromes is seen: cortical myoclonus in combination with ataxia (e.g. progressive myoclonus epilepsy / progressive myoclonus ataxia) or subcortical myoclonus in combination with dystonia. Almost all genetic disorders present with an additional movement disorder. Exceptions include familial cortical myoclonus with epilepsy (BAFME or FCMTE), some epileptic encephalopathies and hyperekplexia. Unfortunately, the majority of the genetic defects causing genetically determined myoclonus syndromes remain unknown.

Identifying the anatomical substrate is not only helpful in the diagnostic process, but also has consequences for the treatment strategy. Levetiracetam, valproic acid and clonazepam are generally considered to be the first choices of treatment in cortical myoclonus, whereas only clonazepam is the first choice in subcortical, spinal and peripheral myoclonus.

Click here to view videos depicting startle and myoclonus (Members Only)

 

Startle syndromes

Startle is a stereotypical response to a sudden and unexpected stimulus. In most instances, the stimulus is acoustic, but other modalities such as tactile, visual, or vestibular are also effective stimuli. Exaggerated startle is a feature of various neurologic and psychiatric conditions. These startle syndromes are a diverse and heterogeneous group of syndromes enfolding three categories: hyperekplexia, stimulus-induced disorders and neuropsychiatric disorders.

Hyperekplexia is a rare genetic clinical syndrome that is characterized by brisk and generalized startle in response to (most often acoustic or tactile) stimulation. The medical triad includes 1) generalized stiffness at birth (slowly diminishing in the first year of life), 2) excessive startle reflexes and 3) short-lasting generalized stiffness following startle resulting in violent falls. The startle response originates from the brainstem and is treated with clonazepam. On examination, at all ages, there is an exaggerated head-retraction reflex. The most common gene affected concerns GLRA1, responsible for 80% of all hyperekplexia pedigrees.

Stimulus induced disorders show excessive responses due to a startling stimulus. These disorders are either non-epileptic (e.g. paroxysmal kinesigenic dyskinesias, episodic ataxia, cataplexy) or epileptic (e.g. reflex epilepsy) and usually start in childhood. The third group, the neuropsychiatric startle syndromes often develop later in life and include startle-induced tics, functional startle syndromes and anxiety disorders (e.g. posttraumatic stress syndrome), and the culture-specific syndromes such as Latah and the Jumping Frenchmen of Maine.

 

Find reference(s) to Myoclonus here:

Education

Journal CME
Receive CME credit on articles related to myoclonus
 

International Congress

Abstracts
Search abstracts on PD submitted to the International Congress (Hong Kong)

Scientific Program
View the Final Program to find topics regarding PD at the International Congress (Hong Kong)

Teaching and Themed Courses
Order streaming content of the Teaching Courses or Themed Courses from past Congresses
 

Announcements

Find conferences pertaining to myoclonus scheduled in 2019

Supported and Endorsed Meetings
Find meetings supported and endorsed by MDS pertaining to myoclonus
 

Publications

Movement Disorders Journal
Find articles on myoclonus from the MDS Journal

Movement Disorders Clinical Practice
Movement Disorders Clinical Practice is an online journal committed to publishing high-quality, peer reviewed articles related to clinical aspects of movement disorders.

Video Library
Search for video on myoclonus in the Movement Disorders Journal supplements (Members Only)

Reviews & Position Papers
View complete collection of Evidence-Based Medicine reviews and task force papers published in the Movement Disorders Journal

Moving Along
Find articles on myoclonus in the Moving Along newsletter

 

Top

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice